Table 4 Evaluation of risks for colorectal cancer
From: High expression of FABP4 and FABP6 in patients with colorectal cancer
Variable | Unadjusted | P value | Adjusted | P value |
|---|---|---|---|---|
OR (95% CI) | OR (95% CI) | |||
BMI (kg/m2) | 1.499 (0.710, 3.166) | 0.289 | --- | --- |
WHR | 2.138 (1.002, 4.584) | 0.037 | 2.084 (0.949, 4.578) | 0.047 |
SBP (mmHg) | 1.286 (0.815, 1.641) | 0.055 | 1.258 (0.565, 2.802) | 0.575 |
DBP (mmHg) | 1.372 (0.993, 1.707) | 0.051 | 1.034 (0.856, 1.413) | 0.064 |
TCH (mmol/L) | 0.522 (0.209, 1.307) | 0.165 | --- | --- |
TG (mmol/L) | 0.927 (0.508, 1.692) | 0.805 | --- | --- |
LDL-C (mmol/L) | 4.301 (3.271, 5.432) | < 0.001 | 4.197 (3.144, 5.393) | < 0.001 |
HDL-C (mmol/L) | 0.078 (0.028, 0.218) | < 0.001 | 0.124 (0.057, 0.274) | < 0.001 |
FPG (mmol/L) | 0.979 (0.274, 3.493) | 0.974 | --- | --- |
FABP4 (pg/ml) | 2.141 (1.352, 3.074) | < 0.001 | 1.916 (1.340, 2.492) | < 0.001 |
FABP6 (pg/ml) | 2.767 (1.517, 3.826) | < 0.001 | 2.162 (1.046,1.078) | < 0.001 |
CEA (ng/ml) | 1.940 (1.038, 3.479) | 0.026 | 1.713 (1.026, 3.236) | 0.040 |
CA19-9 (U/ml) | 3.516 (0.938, 6.186) | 0.062 | --- | --- |
Family history of CRC | 7.298 (5.210, 9.747) | < 0.001 | 5.119(3.940, 7.569) | < 0.001 |